Ameriprise’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,748,127
| Closed | -$149M | – | 3892 |
|
|
2020
Q3 | $149M | Sell |
1,748,127
-1,342,046
| -43% | -$67.9M | 0.06% | 314 |
|
|
2020
Q2 | $110M | Sell |
3,090,173
-2,106,351
| -41% | -$61.6M | 0.05% | 367 |
|
|
2020
Q1 | $70M | Buy |
5,196,524
+852,321
| +20% | +$14.3M | 0.04% | 443 |
|
|
2019
Q4 | $91.9M | Buy |
4,344,203
+2,047,713
| +89% | +$36.1M | 0.04% | 447 |
|
|
2019
Q3 | $30.5M | Buy |
2,296,490
+269,599
| +13% | +$3.96M | 0.01% | 878 |
|
|
2019
Q2 | $28.1M | Buy |
2,026,891
+453,503
| +29% | +$6.82M | 0.01% | 945 |
|
|
2019
Q1 | $30.2M | Buy |
1,573,388
+339,115
| +27% | +$5.47M | 0.01% | 903 |
|
|
2018
Q4 | $17.6M | Buy |
1,234,273
+144,436
| +13% | +$2.87M | 0.01% | 1131 |
|
|
2018
Q3 | $22.7M | Buy |
1,089,837
+33,675
| +3% | +$798K | 0.01% | 1200 |
|
|
2018
Q2 | $25M | Sell |
1,056,162
-171,554
| -14% | -$3.45M | 0.01% | 1039 |
|
|
2018
Q1 | $17.9M | Buy |
1,227,716
+627,077
| +104% | +$10.2M | 0.01% | 1202 |
|
|
2017
Q4 | $9.71M | Buy |
600,639
+16,331
| +3% | +$193K | ﹤0.01% | 1641 |
|
|
2017
Q3 | $8.17M | Sell |
584,308
-226,429
| -28% | -$2.26M | ﹤0.01% | 1735 |
|
|
2017
Q2 | $7.16M | Buy |
810,737
+544,504
| +205% | +$3.82M | ﹤0.01% | 1810 |
|
|
2017
Q1 | $1.72M | Buy |
+266,233
| New | +$1.35M | ﹤0.01% | 2645 |
|
|
2014
Q4 | – | Sell |
-2,596
| Closed | -$10K | – | 4654 |
|
|
2014
Q3 | $10K | Sell |
2,596
-10
| -0.4% | -$34 | ﹤0.01% | 4844 |
|
|
2014
Q2 | $10K | Sell |
2,606
-120
| -4% | -$441 | ﹤0.01% | 4676 |
|
|
2014
Q1 | $12K | Buy |
2,726
+1,075
| +65% | +$5.33K | ﹤0.01% | 4461 |
|
|
2013
Q4 | $8K | Sell |
1,651
-4,560
| -73% | -$20.3K | ﹤0.01% | 4479 |
|
|
2013
Q3 | $38K | Buy |
6,211
+120
| +2% | +$691 | ﹤0.01% | 3985 |
|
|
2013
Q2 | $33K | Buy |
+6,091
| New | +$20K | ﹤0.01% | 3973 |
|
Ameriprise's IMMU Position: Q4 2020 in Review
Ameriprise sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,748,127 shares — an estimated $149M sold.
Ameriprise first reported a position in IMMU in Q2 2013 and held it in 21 quarters. The position peaked at $149M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Ameriprise reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Ameriprise sold 1,748,127 Immunomedics Inc shares in Q4 2020, an estimated $149M.
- Ameriprise first reported a position in Immunomedics Inc in Q2 2013 and held it in 21 quarters.
- Ameriprise's Immunomedics Inc position peaked at $149M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Ameriprise's 13F filing for Q4 2020, filed 12 Feb 2021.